Pathogen: clinical or host-associated sample from ... - BioSample - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Pathogen: clinical or host-associated sample from Proteus mirabilis

Identifiers: BioSample: SAMN36729017; Sample name: BWH_195_P_mir; SRA: SRS18433678

Organism: Proteus mirabilis
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Morganellaceae; Proteus

Package: Pathogen: clinical or host-associated; version 1.0

Attributes

isolate	BWH_195_P_mir
collected by	Brigham and Women's Hospital
collection date	2022
geographic location	USA:Boston
host	Homo sapiens
host disease	Urinary tract infection
isolation source	urine
latitude and longitude	42.3362 N 71.1067 W
host age	30

BioProject: PRJNA278886
Retrieve all samples from this project

Submission: Brigham and Women's Hospital, Jay Worley; 2023-07-27

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Laboratory typing platform	Vendor	Laboratory typing method version or reagent	Testing standard
amikacin	susceptible	<=	2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
amoxicillin-clavulanic acid	susceptible	==	4/2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ampicillin	susceptible	<=	2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefazolin	susceptible	<=	4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefepime	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefoxitin	susceptible	<=	4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftazidime	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftriaxone	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ciprofloxacin	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
gentamicin	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
levofloxacin	susceptible	<=	0.12	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
meropenem	susceptible	==	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
nitrofurantoin	resistant	==	128.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
piperacillin-tazobactam	susceptible	<=	4/4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tetracycline	resistant	>=	16	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tobramycin	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
trimethoprim-sulfamethoxazole	susceptible	<=	1/19	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI

Accession:: SAMN36729017
ID:: 36729017

BioProject SRA Nucleotide

Supplemental Content

Related information

BioProject
BioProject links
SRA
Links to SRA experiments
Nucleotide
Nucleotide links
Assembly
Assembly
Taxonomy
Links to Taxonomy

Recent activity

Clear Turn Off Turn On

Pathogen: clinical or host-associated sample from Proteus mirabilis
Pathogen: clinical or host-associated sample from Proteus mirabilis

biosample
Pathogen: clinical or host-associated sample from Enterococcus faecalis
Pathogen: clinical or host-associated sample from Enterococcus faecalis

biosample
Microbe sample from Clostridioides difficile
Microbe sample from Clostridioides difficile

biosample
Pathogen: clinical or host-associated sample from Clostridioides difficile
Pathogen: clinical or host-associated sample from Clostridioides difficile

biosample
Pathogen: clinical or host-associated sample from Staphylococcus aureus
Pathogen: clinical or host-associated sample from Staphylococcus aureus

biosample

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > DNA & RNA > BioSample